I would like to make it quite clear that this is not an attack on my medical colleagues alone. I am aware that many of my pharmacist colleagues are in the same bewildered state as the more unobservant doctor. This Is deplorable. I would say that pharmacists who do not know their drugs really ought to ask themselves whether they can, in all conscience, still -call themselves " pharmaceutical chemists." I would appeal to all, doctor and pharmacist alike, to take drugs more seriously. If we do not know our tools how can we pick the best for the task in hand and gauge the vigour with which to use them ? There are, these days, aids galoreour patients are entitled to expect us to use them. The results from both groups of patients are summarized in Figs. 1 and 2 . There was an increase in the mean serum F.D.P. following both abdominal surgery and acute myocardial infarction which was highly significant (P<0001) on days 5 and 7 in the postoperative group and days 3 and 4 in the myocardial infarction group. In three of the 11 surgical patients there was a sudden increase on the third postoperative day which was well outside the range found in the remaining eight patients. Reference to the clinical notes revealed that in one of these patients the diagnosis of pulmonary infarction was made on the same day that a serum F.D.P. value of 336 jug./ml. was recorded.
There was no clinical evidence of pulmonary embolus, infarction, or venous thrombosis In the two other patients whose serum F.D.P. peaked during the study. One of the 12 acute myocardial infarction patients also produced a peak of serum F.D.P. without clinical evidence of pulmonary embolus or venous thrombosis. However, during the night on the ninth day after admission he died suddenly and unexpectedly. Necropsy revealed the cause of death to be multiple pulmonary emboli.
It would be premature to conclude from this small pilot study that the quantitative assay of these serum polypeptides will prove to be useful in establishing the diagnosis of suspected or occult pulmonary embolism. We believe that the beneficial effect obtained by this drug casts further doubt on the so-called " immunosuppressive " mechanism of action of this agent in this condition, and in fact attests to our ignorance of the mechanism of action of any of these newer drugs in the various forms of glomerular disease. Our subsequent experience with this agent in children with the nephrotic syndrome is similar to that which we originally reported, and it is our opinion that a clear definition of the specific indications for its use is beginning to emerge. We have been concerned by the occasional instances of fatal varicella in children receiving cyclophosphamide for the nephrotic syndrome which have been reported by others, and for this reason we urge the greatest caution in the use of this drug in patients who have not experienced varicella unless it is possible to avoid exposure to this
